Nanobiotix S.A.(NBTX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,556 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
NBTX Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Nanobiotix S.A. (NBTX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NBTX at 28.4/100 on a 32-signal composite quality model, placing it at rank #2,556 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of NBTX by reported 13-F value include JOHNSON & JOHNSON, MORGAN STANLEY, JANE STREET GROUP, based on the most recent SEC filings. NBTX trades on the Nasdaq exchange and files with the SEC under CIK 1760854. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NBTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nanobiotix S.A. directly from SEC EDGAR. Nanobiotix S.A.'s 13F Pro composite quality score has ranged between 28 and 29 since 2026, currently 28.4 — a stable long-term trajectory across 18 quarterly and live scoring snapshots.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+553.2% YoYTotal Assets
+0.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $32.6M +553.2% | $-7.2M -119.9% | $36.2M +658.1% | $4.8M +80.4% | $2.6M +5.4% | $2.5M |
| Total Assets | $67.8M +0.5% | $67.4M -28.2% | $93.9M +57.1% | $59.8M -41.3% | $101.8M -24.1% | $134.0M |
Get alerted when NBTX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Nanobiotix S.A. including:
Top Institutional Holders of NBTX
JOHNSON & JOHNSON
$212.0M5,623,816 shMORGAN STANLEY
$1.9M49,789 shJANE STREET GROUP, LLC
$1.2M32,180 shHRT FINANCIAL LP
$1.0M27,332 shXTX Topco Ltd
$597.7K15,855 shOptiver Holding B.V.
$513.9K13,631 shMARSHALL WACE, LLP
$378.7K10,044 shCITADEL ADVISORS LLC
$227.8K6,042 shBNP PARIBAS FINANCIAL MARKETS
$152.5K4,044 shUBS Group AG
$97.2K2,577 sh
| Fund | Value | Shares |
|---|---|---|
| JOHNSON & JOHNSON | $212.0M | 5,623,816 |
| MORGAN STANLEY | $1.9M | 49,789 |
| JANE STREET GROUP, LLC | $1.2M | 32,180 |
| HRT FINANCIAL LP | $1.0M | 27,332 |
| XTX Topco Ltd | $597.7K | 15,855 |
| Optiver Holding B.V. | $513.9K | 13,631 |
| MARSHALL WACE, LLP | $378.7K | 10,044 |
| CITADEL ADVISORS LLC | $227.8K | 6,042 |
| BNP PARIBAS FINANCIAL MARKETS | $152.5K | 4,044 |
| UBS Group AG | $97.2K | 2,577 |
Companies Similar to NBTX
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Intercure Ltd.
TRINITY BIOTECH PLC
Cellectis S.A.
MANNATECH INC
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put NBTX on your watchlist
Track score changes the day Nanobiotix S.A. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NBTX a good stock to buy?
13F Pro's AI-powered analysis of Nanobiotix S.A. (NBTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NBTX are available on the NBTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NBTX is classified as a small company.
Which hedge funds own NBTX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NBTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Nanobiotix S.A.'s investment landscape.